AlphAIAlphAI — Financial news for AI agents
theglobeandmail.comSEP 242 min read$GD

Analysts Conflicted on These NA Names: General Dynamics (GD), Rapport Therapeutics, Inc. (RAPP) and First Solar (FSLR)

Analysts updated ratings for General Dynamics (GD), Rapport Therapeutics (RAPP), and First Solar (FSLR). GD received a Hold rating with a $407 target; consensus is $425.62. RAPP got a Buy rating with a $66 target; consensus is $62.29. FSLR maintained a Buy rating with a $323 target; consensus is $268.25. All targets imply significant upside from current prices.

Original reporting
theglobeandmail.com
Published Sep 24, 2026, 10:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 11:54 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Analysts Conflicted on These NA Names: General Dynamics (GD), Rapport Therapeutics, Inc. (RAPP) and First Solar (FSLR) — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

$GDNeutralMed
01

Why it matters

The new targets suggest modest upside for GD and stronger upside for RAPP and FSLR, offering short‑to‑mid‑term trading ideas.

02

Market read

Analyst rating changes can move stock prices; these updates are the primary catalyst for the three names.

03

What to watch

Potential supply‑chain constraints for GD and policy risk for solar sector could temper upside.

Relevance 6/10Novelty 6/10Timing: today

Background

Analyst firms released fresh rating updates and price targets for three North American stocks.

Company-level read

Ticker impact

$GDNeutralMedium confidence
Context

Bernstein maintained a Hold rating on General Dynamics with a $407 price target, updating the analyst consensus.

Expected impact

Potential 5‑10% upside if market prices adjust to the new target.

Evidence & confidence

Rating unchanged but price target raised suggests slight positive bias.

$RAPPBullishMedium confidence
Context

H.C. Wainwright kept a Buy rating on Rapport Therapeutics and set a $66 price target, reinforcing a strong‑buy consensus.

Expected impact

Expect 10‑15% upside as investors price in the new target.

Evidence & confidence

Strong‑buy rating and sizable upside relative to current price.

$FSLRBullishMedium confidence
Context

Morgan Stanley maintained a Buy rating on First Solar with a $323 price target, above current levels.

Expected impact

Potential 8‑12% upside if market aligns with the target.

Evidence & confidence

Analyst confidence reflected in a sizable price‑target premium.

Market effects

Sector

Updates may lift the broader defense, biotech, and solar sectors as peers are re‑priced.

Regional

US market sentiment for industrial, healthcare, and renewable‑energy stocks could improve.

Global

Limited to US‑listed companies; no direct global macro effect.

Counterpoint

What could challenge this read

Ratings unchanged for GD may signal caution; investors could wait for earnings before acting.

Key entities

  • Analyst Firm
    Bernstein

    Provided GD rating and target.

  • Analyst Firm
    H.C. Wainwright

    Provided RAPP rating and target.

  • Analyst Firm
    Morgan Stanley

    Provided FSLR rating and target.

Read at source← All news

Related articles

OCT 15
$GDMed

RBC Capital cuts General Dynamics stock price target on Gulfstream outlook

RBC Capital reduced its price target for General Dynamics (NYSE:GD) to $360 from $410, citing a softer Gulfstream delivery outlook. The firm lowered its Q3 2026 delivery estimate to 38 from 41 and full-year 2026 to 160 from 162. General Dynamics recently secured multiple military contracts worth over $248.9 million. The stock trades at $337.21, below its fair value estimate, suggesting potential undervaluation.

investing.com2 min
OCT 15
$GDMed

26) GD: An Aerospace Stock Worth Considering as a New CEO Takes Over

General Dynamics Corp. (GD) named Danny Deep as its next CEO, effective Jan. 1, 2027. Deep, a 25-year veteran, will succeed Phebe Novakovic, who becomes executive chairman. GD reported $52.6B revenue in 2025. The company operates in aerospace, defense, and business aviation. Deep's appointment may present investment opportunities, according to DividendInvestor's editor.

moneyshow.com1 min
OCT 13
$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

247wallst.com7 min